Market Potential for Perfluorocarbon Based Formulations for Use in Pressurized Metered Dosed Inhalers for Pulmonary Drug Delivery

Abstract

The overarching goal of the SEMPer Fi (saving lives with emergency medical perfluorcarbons) program is to develop and commercialize aerosolized therapeutic formulations, based on perfluorocarbon (PFC) chemistry. Advanced development of these formulations are meant to bridge a technology gap that will allow pharmaceutical hydrophilic compounds to be delivered directly to the lungs via a pressurized metered dose inhaler (pMDI). For the military this technology will provide a faster and more efficacious means to target the Hypoxic Pulmonary Vasoconstrictive (HPV) response, which hinders physical and mental performance of military personnel working in hypoxic environments.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Apr 24, 2020
Accession Number
AD1112835

Entities

People

  • Arlen D. Meyers
  • David C. Irwin
  • David I. Pak
  • Thies D. Schroeder

Organizations

  • University of Colorado Health

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Chemical Warfare
  • Chemical Warfare Agents
  • Clinical Trials
  • Department Of Defense
  • Diseases And Disorders
  • Emerging Technology
  • Health Care
  • Health Services
  • High Altitude
  • Lung Diseases
  • Medical Personnel
  • Military Personnel
  • Military Research
  • Nebulizers And Vaporizers
  • Pulmonary Hypertension
  • Standards
  • Therapy

Fields of Study

  • Medicine

Readers

  • Defense Technology Research and Development.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Petroleum Engineering